Cargando…
Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785424/ https://www.ncbi.nlm.nih.gov/pubmed/33418497 http://dx.doi.org/10.1016/j.ebiom.2020.103204 |
_version_ | 1783632440709873664 |
---|---|
author | Ison, Michael G. Scheetz, Marc H. |
author_facet | Ison, Michael G. Scheetz, Marc H. |
author_sort | Ison, Michael G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7785424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77854242021-01-06 Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 Ison, Michael G. Scheetz, Marc H. EBioMedicine Commentary Elsevier 2021-01-06 /pmc/articles/PMC7785424/ /pubmed/33418497 http://dx.doi.org/10.1016/j.ebiom.2020.103204 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Ison, Michael G. Scheetz, Marc H. Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title | Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title_full | Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title_fullStr | Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title_full_unstemmed | Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title_short | Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 |
title_sort | understanding the pharmacokinetics of favipiravir: implications for treatment of influenza and covid-19 |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785424/ https://www.ncbi.nlm.nih.gov/pubmed/33418497 http://dx.doi.org/10.1016/j.ebiom.2020.103204 |
work_keys_str_mv | AT isonmichaelg understandingthepharmacokineticsoffavipiravirimplicationsfortreatmentofinfluenzaandcovid19 AT scheetzmarch understandingthepharmacokineticsoffavipiravirimplicationsfortreatmentofinfluenzaandcovid19 |